accord
ixth
report
intern
committe
taxonomi
virus
king
et
al
genu
flaviviru
famili
flavivirida
contain
speci
known
caus
human
diseas
includ
dengu
viru
denv
yellow
fever
viru
yfv
japanes
enceph
viru
jev
west
nile
viru
wnv
tickborn
enceph
viru
tbev
virus
caus
million
human
infect
year
rang
mild
febril
symptom
fatal
hemorrhagicneurolog
diseas
gubler
guzman
et
al
halstead
thoma
hay
et
al
monath
recent
decad
dramat
increas
movement
human
anim
commod
via
modern
transport
unplan
urban
tropic
develop
countri
lack
adequ
public
health
infrastructur
enabl
pathogen
expand
geograph
rang
caus
major
epidem
artsob
et
al
duffi
et
al
gould
solomon
gubler
flavivirus
small
nm
envelop
singlestrand
positivesens
rna
virus
genom
vari
kb
contain
singl
open
read
frame
orf
flank
untransl
region
utr
approxim
nucleotid
nucleotid
respect
form
specif
secondari
structur
requir
genom
replic
protein
translat
gritsun
gould
lindenbach
et
al
strauss
strauss
translat
orf
lead
synthesi
polyprotein
cleav
host
viral
proteas
releas
structur
nonstructur
viral
protein
harri
et
al
structur
protein
c
prm
e
locat
ntermin
portion
polyprotein
nonstructur
protein
remain
ctermin
portion
polyprotein
lindenbach
et
al
end
genom
possess
type
cap
end
genom
lack
polyadenyl
tail
dong
et
al
flavivirus
also
contain
uniqu
subgenom
small
kb
noncod
rna
present
utr
viral
rna
thought
essenti
viru
replic
cell
modul
pathogen
anim
pijlman
et
al
robi
et
al
recent
ribosom
frameshift
site
identifi
jev
serogroup
give
rise
protein
elong
form
protein
firth
atkin
melian
et
al
ye
et
al
known
year
rna
mani
positivestrand
rna
virus
includ
flavivirus
infecti
transfect
suscept
tissu
cultur
cell
baltimor
b
boyer
haenni
first
report
infect
anim
viru
nucleic
acid
made
colter
et
al
mengoviru
polioviru
wnv
wecker
schafer
eastern
equin
enceph
viru
colter
et
al
wecker
schafer
principl
exploit
molecular
techniqu
improv
bacteri
dna
plasmid
clone
contain
fulllength
complementari
dna
cdna
positivestrand
rna
viru
suitabl
promot
use
produc
infecti
genom
viral
rna
vitro
transcript
dna
clone
enabl
introduct
mutat
viral
genom
consequ
studi
result
phenotyp
ruggli
rice
power
molecular
tool
frequent
refer
revers
genet
infecti
dna
clone
obtain
use
studi
import
viru
properti
virulenceattenu
cell
penetr
replic
host
rang
function
code
noncod
genom
region
howev
construct
often
difficult
involv
clone
mani
subgenom
cdna
fragment
spite
recent
improv
afford
novel
molecular
techniqu
process
still
labori
mani
difficulti
remain
includ
instabl
toxic
viral
sequenc
bacteri
host
gritsun
gould
rice
et
al
ruggli
rice
aim
review
describ
import
histor
step
develop
flaviviru
infecti
clone
summar
differ
revers
genet
strategi
current
use
assess
impact
technolog
understand
control
virus
diseas
racaniello
et
al
show
first
time
full
length
cdna
eukaryot
posit
strand
rna
viru
polioviru
gener
infecti
viru
mammalian
cell
directli
transfect
racaniello
baltimor
achiev
clone
complet
genom
separ
segment
racaniello
baltimor
produc
complet
cdna
copi
genom
bacteri
plasmid
cultur
mammalian
cell
transfect
plasmid
produc
infecti
polioviru
subsequ
develop
polymeras
chain
reaction
pcr
mark
turn
point
infecti
clone
technolog
complet
simplifi
methodolog
clone
longer
necessari
extract
larg
quantiti
viral
rna
infecti
cultur
revers
transcript
mulli
et
al
develop
vitro
transcript
system
use
bacteriophag
promot
also
becam
possibl
synthes
vitro
full
length
viral
rna
much
higher
effici
compar
cdna
transcript
cell
furthermor
develop
effici
transfect
methodolog
use
cation
liposom
malon
et
al
electropor
improv
effici
rna
transfect
cultur
cell
thu
basic
methodolog
revers
genet
technolog
establish
first
revers
genet
model
studi
flavivirus
publish
rice
et
al
polioviru
complet
genom
sequenc
yfv
vaccin
strain
determin
rice
et
al
result
profound
reorgan
classif
arbovirus
flavivirus
alphavirus
assign
differ
famili
use
data
genom
organ
development
work
clone
complet
genom
bacteri
plasmid
prove
imposs
due
instabl
construct
escherichia
coli
difficulti
circumv
clone
two
segment
genom
separ
plasmid
assembl
vitro
ligat
amplifi
vitro
transcript
transfect
cell
rice
et
al
subsequ
revers
genet
model
describ
number
flavivirus
name
jev
sumiyoshi
et
al
denv
kapoor
et
al
kinney
et
al
lai
et
al
polo
et
al
puri
et
al
kunjin
viru
kunv
khromykh
westaway
murray
valley
viru
mvv
hurrelbrink
et
al
tbev
mandl
et
al
wnv
yamshchikov
et
al
yfv
vaccin
strain
alway
possibl
obtain
fulllength
cdna
clone
singl
plasmid
eg
jev
kapoor
et
al
sumiyoshi
et
al
thu
two
clone
contain
roughli
half
genom
cdna
gener
use
stage
develop
period
mani
step
includ
subclon
correct
mutat
introduc
errorpron
dna
polymeras
exchang
plasmid
backbon
requir
often
involv
sever
year
addit
work
late
race
obtain
revers
genet
model
flavivirus
took
advantag
mani
technolog
advanc
new
strategi
describ
circumv
difficulti
edmond
et
al
gritsun
gould
khromykh
et
al
rice
et
al
ruggli
rice
exampl
develop
pcr
well
revers
transcript
pcr
rtpcr
particular
improv
term
fidel
process
speed
paradigm
shift
barn
cheng
et
al
gould
improv
encourag
virologist
develop
varieti
revers
genet
system
howev
commerci
kit
avail
consequ
scientist
develop
protocol
develop
avail
reliabl
commerci
molecular
biolog
kit
significantli
acceler
virolog
research
capabl
development
period
varieti
method
report
achiev
similar
object
exampl
use
long
highfidel
pcr
combin
long
rt
provid
new
approach
construct
recombin
virus
gould
gritsun
et
al
pioneer
work
gritsun
gould
significantli
improv
method
use
combin
primer
set
optim
concentr
gritsun
gould
produc
two
long
overlap
pcr
product
kb
rtpcr
ligat
transcrib
fulllength
viral
rna
use
principl
infecti
fulllength
rna
transcript
realiz
even
situat
viru
genom
could
easili
clone
bacteria
moreov
avoid
need
viru
purif
shorten
time
produc
engin
viru
year
day
howev
despit
success
gener
infecti
transcript
long
rtpcr
amplicon
without
clone
stabl
fulllength
clone
viru
genom
still
valuabl
genet
resourc
dna
ultim
rna
manipul
improv
sequenc
method
anoth
essenti
requir
gener
revers
genet
model
sanger
method
dideoxi
chaintermin
tradit
approach
dna
sequenc
sanger
et
al
initi
method
complet
manual
use
radioact
ladder
display
huge
acrylamid
gel
subsequ
radioisotop
replac
use
four
differ
fluoresc
dye
sequenc
reaction
smith
et
al
improv
rapidli
led
develop
first
autom
fluoresc
dna
sequenc
ansorg
et
al
ansorg
et
al
brumbaugh
et
al
hood
et
al
hunkapil
hunkapil
et
al
prober
et
al
smith
next
breakthrough
made
descript
first
high
electr
field
separ
dna
sequenc
fragment
use
capillari
electrophoresi
swerdlow
gesteland
first
adapt
display
result
array
zagurski
mccormick
adapt
first
commerci
autom
dna
sequenc
use
capillari
electrophoresi
rather
slab
gel
becam
avail
new
autom
machin
accumul
dna
sequenc
data
acceler
rapidli
earli
pioneer
sequenc
databas
margaret
dayhoff
previous
establish
protein
sequenc
databas
publish
first
collect
nucleotid
sequenc
inform
dayhoff
et
al
shortli
thereaft
genbank
creat
nation
institut
health
usa
genbank
provid
time
central
access
repositori
genet
sequenc
bilofski
et
al
parallel
growth
databas
method
prepar
robust
sequenc
align
detail
comparison
soon
becam
ratelimit
step
analysi
sequenc
data
develop
rapid
search
program
fasta
pearson
lipman
blast
altschul
et
al
made
practic
identifi
gene
new
sequenc
comparison
sequenc
alreadi
databas
bioinformat
infanc
suddenli
becam
essenti
interpret
sequenc
data
gener
testabl
hypothes
aris
data
first
sequenc
analysi
softwar
began
appear
mega
offer
possibl
produc
phylogenet
tree
nucleotid
amino
acid
sequenc
align
kumar
et
al
product
softwar
analysi
sequenc
data
major
growth
industri
new
improv
method
appear
frequent
autom
sanger
dna
sequenc
method
recogn
firstgener
technolog
newer
dna
sequenc
method
refer
nextgener
sequenc
ng
new
technolog
util
variou
strategi
reli
fig
gener
procedur
infecti
clone
construct
doubl
strand
cdna
copi
rna
viru
genom
stabli
incorpor
vector
amplifi
host
purif
construct
infecti
virus
obtain
either
direct
transfect
permiss
cell
eukaryot
promot
use
transfect
genom
rna
obtain
vitro
transcript
bacteriophag
promot
use
differ
combin
templat
prepar
sequenc
imag
high
speed
data
analysi
throughput
capac
produc
enorm
quantiti
sequenc
data
rapidli
increasingli
lower
cost
first
nextgener
highthroughput
sequenc
technolog
flx
pyrosequenc
platform
becam
avail
earli
illumina
releas
genom
analyz
solid
releas
glenn
technolog
aspect
sequenc
analysi
expand
rapidli
novel
improv
platform
continu
develop
releas
recent
exampl
includ
heliscop
ion
torrent
pgm
becam
avail
import
consequ
develop
complet
sequenc
obtain
rapidli
regardless
origin
whether
alreadi
known
rapid
progress
total
alter
speed
eas
revers
genet
system
produc
use
studi
previous
inaccess
subject
dna
synthesi
techniqu
technolog
also
evolv
rapidli
meet
new
scientif
demand
entir
genom
synthes
demand
increas
de
novo
synthesi
becom
cheap
altern
obtain
clone
cdna
one
mani
consequ
improv
methodolog
technic
possibl
resuscit
virus
infecti
virion
exist
cello
et
al
tumpey
et
al
theori
possibl
creat
novel
virus
synthet
approach
first
explor
blight
et
al
creation
replicationcompet
hcv
rna
replicon
blight
et
al
earli
stage
develop
lack
adapt
technolog
time
constraint
primari
obstacl
gener
revers
genet
model
today
product
revers
genet
system
rel
simpl
step
toward
understand
mechan
govern
biolog
function
virus
revers
genet
defin
gener
viru
entir
cdna
neumann
kawaoka
power
tool
studi
virus
rel
easi
manipul
technic
short
viru
replic
cycl
facilit
bacteriafre
approach
gener
procedur
product
tbev
use
long
pcr
two
long
pcr
product
either
ligat
use
restrict
enzym
merg
fusion
pcr
vitro
transcript
inocul
fulllength
rna
transcript
intracerebr
young
mice
infecti
virus
recov
fig
bacteriafre
approach
gener
procedur
product
kunv
use
cpec
reaction
phusion
highfidel
dna
polymeras
use
assembl
incorpor
multipl
rtpcr
amplicon
vector
gener
circular
product
transfect
directli
compet
cell
recov
infecti
virus
rapid
phenotyp
express
modifi
virus
potenti
use
vaccin
vector
analysi
viral
gene
noncod
sequenc
even
studi
life
cycl
pathogenesi
transmiss
commonli
use
power
revers
genet
system
studi
flavivirus
known
infecti
clone
see
fig
altern
system
develop
describ
see
fig
infecti
clone
cdna
copi
rna
viru
genom
stabli
incorpor
vector
genom
rna
obtain
vitro
transcript
rna
potenti
infecti
transfect
appropri
cell
lead
recoveri
infecti
viru
manipul
virus
genet
cdna
copi
rna
genom
clone
requir
cdna
modifi
sitedirect
mutagenesi
de
novo
synthesi
use
residu
introduc
restrict
site
appropri
plasmid
cosmid
bacteria
varieti
yeast
use
vector
clone
cdna
presenc
dna
depend
rna
polymeras
promot
end
sequenc
requir
enabl
effici
gener
viral
rna
either
vitro
transcript
cdna
direct
transfect
permiss
cell
ruggli
rice
see
fig
transfect
transcrib
genom
rna
direct
vivo
inocul
suscept
anim
also
shown
rescu
infecti
viru
gritsun
gould
see
fig
case
antigenom
hepat
delta
viru
ribozym
ad
end
viral
genom
perrotta
ribozym
sequenc
selfcleav
cell
leav
entir
viral
rna
genom
intact
avail
replic
cellular
machineri
whilst
flaviviru
infecti
clone
provid
power
tool
studi
mani
aspect
virus
construct
fulllength
cdna
molecul
bacteri
vector
problemat
labori
time
consum
often
unstabl
contain
unwant
induc
substitut
may
toxic
bacteria
due
viral
protein
express
variou
approach
employ
overcom
problem
use
differ
host
vector
promot
strategi
mutat
cryptic
bacteri
promot
site
flaviviru
genom
complet
sequenc
genom
known
altern
extrem
end
genom
known
obtain
pool
high
fidel
fulllength
cdna
first
step
produc
infecti
clone
earli
method
usual
use
subclon
step
product
short
cdna
fragment
link
togeth
ligat
clone
fulllength
cdna
molecul
case
first
flaviviru
infecti
clone
use
two
plasmid
vitro
ligat
method
assembl
full
length
templat
transcript
rice
et
al
subsequ
improv
pcr
enzym
fidel
optim
reaction
condit
led
major
increas
achiev
length
authent
cdna
amplicon
final
enabl
rapid
amplif
genom
length
cdna
barn
gritsun
gould
indic
fig
bacteriafre
approach
gener
procedur
product
denv
use
gibson
assembl
method
use
combin
three
enzym
exonucleas
dna
polymeras
dna
ligas
multipl
rtpcr
amplicon
viru
vector
assembl
isotherm
singlereact
gener
circular
product
transfect
directli
compet
cell
recov
infecti
virus
bacteriafre
approach
gener
procedur
product
flavivirus
use
isa
method
entir
viral
genom
flank
extrem
human
cytomegaloviru
promot
pcmv
extrem
hepat
delta
ribozym
follow
simian
viru
polyadenyl
signal
hdr
amplifi
pcr
three
overlap
cdna
fragment
direct
transfect
pcr
product
compet
cell
enabl
recoveri
infecti
virus
success
appli
denv
yfv
jev
tbev
earlier
de
novo
synthesi
genom
length
cdna
possibl
current
first
method
choic
regardless
method
use
sequenc
entir
genom
deriv
infecti
clone
must
determin
compar
parent
viru
choic
host
clone
cdna
bacteria
differ
strain
e
coli
express
system
commonli
use
express
system
clone
cdna
physiolog
genet
bacteria
welldefin
varieti
differ
host
strain
variou
genet
background
avail
give
differ
specif
characterist
maxim
chanc
success
clone
casali
optim
strain
may
select
contain
one
sever
differ
antibiot
resist
gene
eg
chloramphenicol
ampicillin
tetracyclin
streptomycin
carri
chromosom
copi
gene
like
rna
polymeras
gene
specif
design
clone
larg
fragment
dna
possess
possess
specifi
restrictionmodif
system
grow
fast
turbo
strain
also
harbor
mutat
decreas
effici
invalid
recombin
system
thu
increas
integr
clone
dna
direct
invert
repeat
present
high
transform
effici
novablu
methyl
dna
even
reduc
copi
number
plasmid
toxic
protein
abl
c
howev
perfect
univers
strain
capabl
amplifi
limit
toxic
flaviviru
infecti
clone
therefor
necessari
determin
empir
one
suitabl
sequenc
vector
use
thu
differ
e
coli
strain
use
construct
stabl
fulllength
cdna
chimer
viru
blaney
et
al
blaney
et
al
tbev
pletnev
et
al
strain
use
construct
first
major
flaviviru
infecti
clone
previous
describ
nicola
ruggli
charl
rice
ruggli
rice
differ
vector
sinc
begin
molecular
clone
earli
number
vector
creat
increas
enorm
therefor
optim
vector
choic
difficult
import
increas
success
obtain
final
construct
varieti
criteria
taken
account
insert
size
copi
number
select
marker
plasmid
mainten
propag
plasmid
e
coli
cell
ineffici
process
cell
contain
plasmid
growth
advantag
given
replic
chromosom
addit
plasmid
dna
method
select
cell
receiv
plasmid
therefor
requir
appropri
select
pressur
must
impos
mainten
enhanc
plasmid
almost
convent
plasmid
use
antibiot
resist
gene
carri
backbon
vector
select
marker
thu
addit
appropri
antibiot
growth
medium
kill
cell
contain
plasmid
produc
cultur
cell
contain
plasmid
mani
case
choic
antibiot
restrict
howev
clone
strain
e
coli
inher
resist
antibiot
thu
case
antibiot
use
select
cell
carri
plasmid
interest
genotyp
desir
clone
strain
check
prior
clone
theori
gener
clone
plasmid
carri
dna
insert
around
kb
size
insert
excess
size
may
place
constraint
effici
replic
plasmid
particularli
highcopynumb
vector
caus
problem
insert
stabil
sever
type
vector
avail
clone
larger
fragment
dna
plasmid
maintain
differ
copi
number
depend
origin
replic
major
case
piec
dna
clone
conserv
amplif
subsequ
manipul
high
yield
recombin
plasmid
e
coli
cultur
prefer
choic
howev
highcopynumb
may
caus
problem
clone
dna
especi
case
flavivirus
exist
within
genom
one
cryptic
prokaryot
promot
facilit
product
viral
protein
toxic
bacteria
high
level
even
protein
express
poorli
clone
dna
presenc
mani
copi
plasmid
may
rais
level
protein
toxic
level
case
recombin
still
obtain
growth
rate
often
frustratingli
slow
clone
foreign
dna
sequenc
often
unstabl
blaney
et
al
ruggli
rice
ward
davidson
solv
problem
lowcopynumb
vector
develop
tightli
regul
prokaryot
promot
maintain
low
level
basal
express
prokaryot
transcript
termin
prevent
spuriou
transcript
foreign
dna
sequenc
upstream
plasmid
promot
strategi
use
obtain
sever
infecti
clone
exampl
tbev
cdna
clone
low
copi
number
plasmid
gritsun
gould
wherea
murray
valley
enceph
viru
mvev
prototyp
strain
insert
lowcopynumb
plasmid
vector
hurrelbrink
et
al
complet
fulllength
cdna
yfv
insert
control
promot
low
copi
number
plasmid
bredenbeek
et
al
similar
approach
use
differ
strain
kinney
et
al
polo
et
al
zhu
et
al
wnv
shi
et
al
yamshchikov
et
al
kunv
khromykh
westaway
tbev
mandl
et
al
howev
alway
resolv
problem
exampl
sever
attempt
construct
genet
stabl
jev
cdna
use
low
medium
highcopynumb
plasmid
special
bacteri
host
fail
mishin
et
al
sumiyoshi
et
al
sumiyoshi
et
al
bacteri
artifici
chromosom
bacteri
artifici
chromosom
bac
circular
dna
molecul
capabl
maintain
larg
dna
insert
kb
use
instead
plasmid
vector
assembl
infecti
clone
base
e
coli
fertil
factor
ffactor
replicon
maintain
circular
supercoil
extra
chromosom
singl
copi
plasmid
bacteri
host
monaco
larin
oconnor
et
al
shizuya
et
al
high
capac
suit
primari
use
construct
infecti
clone
larg
dna
virus
baculovirus
luckow
et
al
herpesviru
saeki
et
al
howev
bac
technolog
also
extend
flavivirus
thu
fulllength
jev
cdna
success
obtain
clone
jev
genom
bac
vector
yun
et
al
method
also
appli
yfv
van
der
et
al
suzuki
et
al
pierro
et
al
usmeciro
et
al
suggest
method
suit
bacteria
could
resist
toxic
caus
flaviviru
genom
cosmid
bac
plasmid
vector
use
infecti
clone
construct
inde
zhang
et
al
use
cosmid
vector
expand
vector
convent
vector
contain
small
region
bacteriophag
k
dna
contain
cohes
end
site
co
vector
design
accommod
larg
insert
kb
hohn
collin
prove
suitabl
clone
fulllength
cdna
amplicon
jev
clone
vector
pk
puc
pgem
effici
gener
viral
rna
cdna
vitro
cellulo
vivo
viral
sequenc
need
flank
suitabl
promot
commonli
use
promot
flaviviru
infecti
clone
bacteriophag
promot
lesser
extent
eukaryot
promot
human
cytomegaloviru
refer
cmv
promot
see
fig
advantag
bacteriophag
promot
use
vitro
produc
larg
quantiti
viral
rna
cdna
bacteriophag
rna
polymeras
transcript
transfect
directli
permiss
cell
anim
infecti
viru
recov
gener
polymerasepromot
lower
effici
vitro
transcript
system
ideal
condit
roughli
compar
other
howev
rna
polymeras
error
prone
therefor
rna
transcript
view
genet
homogen
popul
boyer
et
al
sooknanan
et
al
cmv
promot
hand
enabl
viral
rna
produc
cellulo
direct
transfect
fulllength
cdna
eukaryot
cell
eukaryot
promot
success
use
product
infecti
dna
two
strain
wnv
khromykh
et
al
pierson
et
al
well
sever
posit
strand
rna
virus
includ
poliovirus
semler
et
al
footandmouth
diseas
viru
beard
et
al
sever
alphavirus
review
nougaired
et
al
schlesing
dubenski
coronavirus
almazan
et
al
plant
virus
boyer
haenni
johansen
lopezmoya
garcia
use
promot
confer
logist
advantag
bacteriophag
promot
requir
product
rna
vitro
problem
stabil
toxic
bacteria
still
remain
made
particularli
acut
e
coli
transcript
activ
eukaryot
promot
antonucci
et
al
davi
huang
promot
transcript
activ
e
coli
gener
problem
involv
deriv
infecti
clone
construct
infecti
clone
enabl
direct
genet
manipul
viral
genom
valuabl
tool
modern
experiment
virolog
howev
use
practic
import
often
limit
due
instabl
construct
propag
e
coli
problem
particularli
evid
develop
flaviviru
infecti
clone
consequ
viru
infecti
clone
either
almost
imposs
construct
difficult
maintain
e
coli
due
predisposit
spontan
rearrang
andor
acquisit
stabil
mutat
plausibl
explan
instabl
result
unanticip
express
viral
cdna
encod
product
toxic
bacteri
host
thu
differ
strategi
elabor
base
observ
artifici
introduc
delet
insert
frameshift
allevi
clone
problem
either
increas
stabil
construct
decreas
transcript
activ
promot
cryptic
express
viral
protein
reduct
toxic
bacteria
circumv
presenc
promoterlik
sequenc
insid
viral
genom
foreign
gene
cassett
advantag
taken
major
differ
mrna
format
prokaryot
eukaryot
use
eukaryot
rna
process
mechan
essenti
part
clone
stabil
strategi
yamshchikov
et
al
approach
conceiv
observ
singl
nonsens
mutat
result
apparit
prematur
stop
codon
often
suffici
stabil
entir
construct
presum
prevent
synthesi
toxic
product
henc
temporari
ablat
deleteri
express
translat
level
interrupt
orf
help
intron
contain
stop
codon
benefici
propag
recombin
plasmid
e
coli
intron
effect
block
synthesi
toxic
product
bacteri
host
even
spuriou
transcript
result
format
mrna
nuclear
transcript
eukaryot
cell
accompani
splice
primari
transcript
would
lead
precis
excis
intron
restor
origin
orf
viru
infecti
clone
viral
repliconbas
express
vector
subsequ
export
mrna
cytoplasm
translat
result
synthesi
viral
protein
initi
viral
infecti
cycl
replic
vector
rna
use
approach
deleteri
effect
spuriou
transcript
eukaryot
promot
bacteri
cell
elimin
translat
level
insert
intron
viral
cdna
cassett
nevertheless
case
modif
viral
cassett
alway
feasibl
possibl
problem
implement
propos
approach
associ
potenti
exist
cryptic
splice
site
viral
rna
genom
shiu
et
al
howev
potenti
site
found
appear
substanti
impact
function
properti
design
infecti
dna
construct
interrupt
viral
open
read
frame
either
frameshift
mutat
insert
intron
lead
substanti
stabil
plasmid
contain
viral
genom
cassett
control
eukaryot
promot
johansen
lopezmoya
garcia
olsen
johansen
suggest
spuriou
transcript
eukaryot
promot
e
coli
antonucci
et
al
davi
huang
may
substanti
contribut
observ
instabl
report
anoth
approach
investig
tri
determin
decreas
spuriou
transcript
could
elimin
destabil
effect
eukaryot
promot
infecti
dna
construct
thu
describ
altern
minim
approach
base
manipul
promot
minim
activ
bacteria
reduc
deleteri
effect
mishin
et
al
cmv
promot
often
use
drive
express
engin
construct
varieti
mammalian
cell
foeck
hofstett
consist
transcript
activ
minim
promot
region
immedi
adjac
rna
transcript
initi
codon
upstream
enhanc
element
display
transcript
activ
mammalian
cell
thomsen
et
al
use
knowledg
certain
regulatori
element
eukaryot
gene
enhanc
influenc
gene
express
positionand
orientationindepend
manner
jonsson
et
al
enhanc
region
separ
promot
region
move
either
directli
upstream
promot
immedi
follow
polyadenyl
site
delet
enhanc
led
reduct
gene
express
contrast
reloc
cmv
enhanc
downstream
report
gene
discern
effect
gene
product
e
coli
insert
cmv
enhanc
polyadenyl
signal
result
increas
transcript
rate
mammalian
cell
without
affect
stabil
construct
e
coli
approach
resolv
instabl
problem
associ
presenc
viral
genom
cdna
prokaryot
promoterlik
element
johansen
lopezmoya
garcia
olsen
johansen
provid
togeth
intronbas
stabil
approach
flexibl
choic
design
strategi
final
pu
et
al
develop
method
construct
stabl
fulllength
flaviviru
cdna
reduc
intrins
toxic
viral
genom
sequenc
e
coli
pu
et
al
demonstr
instabl
jev
cdna
clone
bacteria
due
toxic
cryptic
express
viral
protein
multipl
put
e
coli
promot
ecp
sequenc
embed
viral
genom
henc
design
new
approach
assembl
infecti
jev
cdna
clone
introduc
silent
mutat
ecp
sequenc
within
jev
genom
silent
mutat
reduc
ecp
activ
result
stabil
fulllength
jev
cdna
clone
e
coli
recent
new
approach
propag
jev
infecti
cdna
clone
bacteria
describ
pu
et
al
tandem
repeat
sequenc
seven
repeat
tetracyclinerespons
element
introduc
upstream
minim
cmv
promot
sequenc
cai
et
al
follow
viral
genom
cryptic
express
jev
protein
bacteria
greatli
reduc
increas
stabil
cdna
clone
without
alter
sequenc
viral
genom
yeast
fulllength
flavivir
cdna
genom
unstabl
e
coli
success
clone
eukaryot
system
often
toler
bacteria
toxic
flaviviru
sequenc
presum
promot
less
cryptic
viral
protein
express
yeast
saccharomyc
cerevisia
popular
eukaryot
host
case
viral
cdna
assembl
homolog
recombin
two
common
strategi
clone
dna
yeast
assembl
yeast
artifici
chromosom
yac
use
yeast
coli
shuttl
vector
use
approach
polo
et
al
assembl
fulllength
cdna
yeast
recombin
vivo
follow
transform
e
coli
produc
plasmid
dna
vitro
transcript
polo
et
al
similar
approach
also
appli
santo
et
al
even
problem
deleteri
effect
instabl
e
coli
host
complet
elimin
method
enabl
recoveri
infecti
fulllength
rna
transcript
two
method
use
assembl
fulllength
denv
clone
shuttl
vector
approach
simpler
reliabl
yac
approach
essenti
due
need
supplementari
clone
step
infecti
clone
could
recov
yac
bacteria
method
also
use
assembl
fulllength
puri
et
al
kelli
et
al
cdna
current
methodolog
construct
infecti
cdna
clone
timeconsum
unpredict
labori
process
frequent
associ
undesir
mutat
unstabl
toxic
clone
bacteria
order
avoid
need
use
bacteri
host
thu
overcom
problem
relat
use
bacteriafre
approach
develop
genet
engin
infecti
viral
rna
obtain
direct
transcript
use
fulllength
cdna
templat
either
long
rtpcr
fusion
overlap
rtpcr
fragment
without
clone
see
fig
use
rapid
approach
problemat
process
construct
fulllength
cdna
clone
repeat
ligat
avoid
recombin
virus
made
within
day
strategi
first
use
gritsun
gould
siberian
subtyp
vs
tbev
gritsun
gould
procedur
develop
base
high
fidel
high
yield
long
pcr
protocol
describ
barn
cheng
et
al
util
mixtur
two
thermost
dna
polymeras
one
possess
exonucleas
proofread
activ
produc
two
overlap
cdna
product
kb
length
repres
fulllength
genom
viru
barn
cheng
et
al
half
cdna
design
contain
promot
ad
first
forward
primer
fulllength
cdna
vs
viru
produc
either
ligat
two
overlap
dna
molecul
uniqu
restrict
site
fusion
pcr
directli
inocul
intracerebr
mice
vitro
transcrib
rna
templat
infecti
method
avoid
need
viru
purif
cdna
clone
procedur
shorten
time
produc
engin
viru
year
day
first
report
infecti
rna
viru
deriv
pcr
without
intermedi
clone
cdna
microbi
vector
altern
edmond
et
al
develop
anoth
approach
rapid
gener
kunv
infecti
cdna
complet
elimin
need
plasmid
dna
propag
bacteria
vitro
rna
transcript
edmond
et
al
see
fig
approach
base
use
circular
polymeras
extens
clone
cpec
reaction
phusion
highfidel
dna
polymeras
assembl
multipl
rtpcr
amplicon
right
order
vector
purpos
rtpcr
fragment
contain
overlap
end
first
last
rtpcr
amplicon
also
overlap
end
vector
fragment
ensur
fragment
vector
mix
denatur
overlap
end
anneal
dna
polymeras
extend
fragment
use
neighbor
fragment
primer
overlap
fragment
design
similar
anneal
temperatur
reaction
gener
circular
end
product
gener
circular
product
transfect
directli
compet
cell
without
addit
manipul
sinc
vitro
rna
transcript
step
elimin
replac
polymeras
promot
cmv
promot
thu
allow
transcript
viral
rna
cell
directli
plasmid
dna
cellular
rna
polymeras
ii
edmond
et
al
base
principl
siridechadilok
et
al
use
gibson
assembl
combin
three
enzym
activ
exonucleas
dna
polymeras
dna
ligas
assembl
multipl
overlap
dna
fragment
isotherm
singlereact
reconstruct
denv
genom
multipl
pcr
product
amplifi
cdna
onto
express
plasmid
cmv
promot
precis
initi
transcript
viru
genom
sequenc
termin
hepat
viru
hdv
ribozym
accur
gener
end
transcrib
viral
rna
siridechadilok
et
al
see
fig
recent
aubri
et
al
describ
new
revers
genet
method
design
isa
infectioussubgenomicamplicon
facilit
product
infecti
wildtyp
genet
modifi
anim
rna
virus
genom
dna
materi
varieti
form
includ
preexist
infecti
clone
viral
rna
de
novo
synthes
dna
genom
sequenc
aubri
et
al
see
fig
procedur
requir
clone
propag
cdna
bacteria
vitro
rna
transcript
entir
genom
amplifi
pcr
dna
fragment
approxim
kb
bp
overlap
region
first
last
fragment
flank
respect
cmv
promot
hepat
delta
ribozym
follow
simian
viru
polyadenyl
signal
pcr
product
mix
transfect
permiss
cell
enabl
recoveri
infecti
virus
unlik
bacterium
free
approach
isa
method
requir
addit
step
besid
pcr
amplif
need
obtain
differ
cdna
fragment
instead
process
proce
natur
cellulo
recombin
greatli
facilit
shorten
procedur
initi
studi
method
success
use
wnv
yfv
jev
tbev
denv
chikungunya
viru
alphaviru
coxsackieviru
picornaviru
viral
rna
polymeras
characterist
exhibit
low
fidel
result
rel
high
mutat
rate
viral
rna
replic
consequ
newli
gener
popul
rna
virus
extrem
heterogen
intrapopul
variabl
describ
mutant
spectrum
phenotyp
given
viru
attribut
consensu
sequenc
establish
mutant
spectrum
whole
respons
phenotyp
ciota
et
al
holm
moya
case
arbovirus
addit
factor
involv
viral
agent
altern
arthropod
vector
vertebr
host
consequ
mutant
spectrum
like
reflect
select
constraint
result
variant
popul
ensur
select
phenotyp
effici
replic
transmiss
host
ciota
et
al
ciota
et
al
coffey
vignuzzi
coffey
et
al
current
revers
genet
system
engin
virus
use
clone
method
experiment
procedur
viral
cdna
clone
vector
plasmid
bac
cosmid
infecti
virus
recov
either
vitro
transcript
use
bacteriophag
rna
polymeras
transfect
permiss
cell
directli
recov
transfect
cell
use
eukaryot
transcript
promot
transfect
cdna
use
recov
infecti
virus
consid
clonal
consequ
stage
mutant
spectrum
present
origin
viru
popul
longer
exist
current
viral
popul
approxim
clonal
obtain
use
either
follow
two
method
product
viral
genom
cdna
clone
plasmid
control
eukaryot
promot
clonal
subgenom
cdna
fragment
eg
plasmid
fragment
use
instead
pcr
product
use
isa
method
potenti
impact
aris
deplet
mutant
spectra
could
result
modif
viral
phenotyp
exampl
observ
virus
recov
use
revers
genet
initi
clonal
popul
replic
slowli
correspond
parent
nonclon
ancestor
coffey
vignuzzi
kinney
et
al
pierro
et
al
exhibit
reduc
neurovirul
rodent
howev
base
consensu
sequenc
mutat
could
identifi
account
differ
phenotyp
exampl
illustr
potenti
limit
revers
genet
sequenc
method
use
investig
basi
viru
pathogenesi
contrast
new
method
describ
involv
bacteri
clone
viral
cdna
provid
opportun
conserv
mutant
spectrum
present
origin
viral
sampl
eg
clinic
sampl
cell
cultur
isol
aubri
et
al
edmond
et
al
siridechadilok
et
al
altern
method
potenti
gener
genet
variabl
complet
differ
initi
divers
sourc
materi
exampl
errorpron
dnadepend
rna
polymeras
introduc
random
mutat
vitro
transcript
viral
rna
genom
clone
cdna
moreov
dna
depend
dna
polymeras
also
gener
error
thu
possibl
use
pcr
enzym
exhibit
differ
level
fidel
could
consid
mean
regul
variant
composit
within
mutant
spectrum
presum
chang
phenotyp
recov
viru
inde
one
could
visual
use
method
investig
underli
basi
viral
pathogenesi
case
arbovirus
examin
impact
alter
mutant
spectra
virusvectorhost
interact
keep
mind
time
wish
exploit
potenti
versatil
revers
genet
method
one
imagin
differ
question
need
rais
elabor
experi
determin
choic
suitabl
revers
genet
system
one
possess
advantag
drawback
exampl
object
studi
effect
one
mutat
work
clonal
viral
popul
could
appropri
would
advantag
work
infecti
clone
equival
method
howev
object
studi
interact
host
viru
would
interest
use
revers
genet
method
conserv
origin
mutant
spectrum
mimic
close
happen
natur
cycl
viru
revers
genet
system
allow
artifici
manipul
viral
genom
sitedirect
mutagenesi
deletioninsert
rearrang
studi
phenotyp
virus
gener
use
method
allow
scientif
commun
gain
valuabl
knowledg
relat
replic
biolog
characterist
pathogenes
viral
agent
describ
recent
select
advanc
aris
studi
flavivirus
base
applic
revers
genet
tabl
earlier
find
describ
ruggli
rice
ruggli
rice
revers
genet
enabl
high
fidel
product
infecti
virus
clone
viral
cdna
util
low
mutat
rate
viral
cdnabear
plasmid
amplif
bacteria
provid
possibl
investig
consequ
replic
fit
introduct
singl
mutat
accordingli
larg
number
genet
defin
viral
mutant
construct
studi
varieti
flavivirus
includ
yfv
muylaert
et
al
denv
leardkamolkarn
et
al
matusan
et
al
jev
sumiyoshi
et
al
ye
et
al
zhao
et
al
wnv
arroyo
et
al
martinaceb
et
al
van
slyke
et
al
tbev
gritsun
et
al
mandl
et
al
yoshii
et
al
exampl
point
mutat
engin
prm
e
protein
chimer
virus
shown
improv
viabil
viral
yield
cell
cultur
virus
contain
singl
point
substitut
utr
exhibit
reduc
replic
fit
cellulo
reduc
neurovirul
newborn
mice
leardkamolkarn
et
al
observ
confirm
sever
flavivirus
delet
engin
utr
caus
attenu
cell
cultur
anim
blaney
et
al
blaney
et
al
cahour
et
al
mandl
et
al
men
et
al
zeng
et
al
five
share
point
mutat
introduc
hing
region
span
domain
ii
e
glycoprotein
jev
residu
wnv
residu
correspond
arroyo
et
al
also
mutat
introduc
upperlater
surfac
domain
iii
tbev
residu
mandl
et
al
exampl
virus
show
reduc
neurovirul
mice
howev
singl
mutat
locat
hing
region
jev
increas
neurovirul
monath
et
al
thu
studi
identifi
direct
associ
specif
viral
genom
region
specif
site
correspond
biolog
properti
viru
addit
link
specif
mutat
alter
viral
replic
virul
characterist
revers
genet
also
enabl
precis
identif
specif
stage
within
viral
replic
cycl
alter
remark
exampl
silent
mutat
gene
vaccin
strain
jev
shown
abolish
format
larg
protein
destabil
conserv
rna
pseudoknot
secondari
structur
respons
occurr
ribosom
frameshift
thu
reduc
neurovirul
neuroinvas
mice
ye
et
al
anoth
studi
mutat
jev
domain
e
protein
direct
impact
viral
spread
cell
cell
increas
viruscel
interact
decreas
viral
entri
effici
zhao
et
al
result
reduc
express
kinet
viral
protein
includ
protein
interferon
ifn
antagonist
lin
et
al
turn
lead
reduc
capac
block
ifn
signal
increas
attenu
phenotyp
liang
et
al
studi
jev
mvev
denv
indic
mutat
domain
ii
iii
e
protein
impair
viru
bind
entri
host
cell
hung
et
al
hurrelbrink
mcminn
liu
et
al
modi
et
al
recent
de
wispelaer
yang
show
mutat
three
conserv
residu
domain
idomain
iii
linker
e
protein
greatli
impair
viral
product
abolish
format
viral
particl
within
cell
de
wispelaer
yang
eas
infecti
clone
genet
modifi
provid
opportun
gain
new
insight
natur
virushost
interact
context
virul
determin
virushost
cell
interact
mechan
evas
underli
host
specif
virul
determin
introduc
mutat
construct
intratypicheterotyp
chimer
virus
numer
virul
determin
identifi
analyz
understand
mechanist
basi
behind
alter
phenotyp
review
hurrelbrink
mcminn
mandl
blaney
et
al
blaney
et
al
cahour
et
al
de
wispelaer
yang
huang
et
al
hung
et
al
leardkamolkarn
et
al
matusan
et
al
men
et
al
modi
et
al
zeng
et
al
jev
arroyo
et
al
liang
et
al
lin
et
al
liu
et
al
monath
et
al
sumiyoshi
et
al
khromykh
westaway
chimer
vaccin
yfv
arroyo
et
al
caufour
et
al
chamber
et
al
guirakhoo
et
al
guirakhoo
et
al
guirakhoo
et
al
monath
et
al
monath
et
al
monath
et
al
monath
et
al
pugachev
et
al
van
der
et
al
denv
bray
lai
bray
et
al
bray
et
al
caufour
et
al
chen
et
al
guirakhoo
et
al
guirakhoo
et
al
guirakhoo
et
al
antivir
denv
qing
et
al
yang
et
al
use
infecti
clone
wnv
pijlman
et
al
show
member
genu
flaviviru
produc
uniqu
abund
noncod
subgenom
rna
element
sfrna
deriv
end
utr
protect
downstream
rna
degrad
cellular
ribonucleas
pijlman
et
al
sfrna
shown
play
import
role
viru
replic
cycl
contribut
viral
cytoand
hostpathogen
wnv
genet
engin
viral
mutant
gener
enabl
identif
larg
number
virul
determin
within
structuralnonstructur
gene
utr
viral
rna
genom
audsley
et
al
borisevich
et
al
liu
et
al
shirato
et
al
whiteman
et
al
wicker
et
al
wicker
et
al
yu
et
al
zhang
et
al
grant
et
al
show
singl
aminoacid
substitut
mousevirul
strain
significantli
reduc
efficaci
viral
rna
synthesi
mammalian
cell
complet
abolish
virulencepathogenesi
mous
model
grant
et
al
also
show
revers
substitut
nonvirul
strain
suffici
make
strain
virul
mous
model
sever
viral
determin
modul
intrins
virul
denv
mice
identifi
shown
affect
either
replic
effici
leardkamolkarn
et
al
bind
properti
bray
et
al
gualano
et
al
prestwood
et
al
similar
result
obtain
jev
strain
aminoacid
substitut
exhibit
increas
virul
mice
tajima
et
al
notabl
correl
growth
properti
cellulo
virul
vivo
alway
observ
inde
yamaguchi
et
al
reveal
amino
acid
substitut
jev
strain
increas
virul
mice
without
influenc
growth
rate
cell
cultur
yamaguchi
et
al
molecular
determin
neuroinvas
neurovirul
also
studi
rumyantsev
et
al
demonstr
inhibit
neuroinvas
langat
viru
lgtv
strain
identifi
amino
acid
substitut
locat
either
e
protein
protein
independ
respons
abolit
neuroinvas
rumyantsev
et
al
likewis
hanley
et
al
demon
strate
replac
sever
pair
charg
amino
acid
alanin
polymeras
protein
decreas
neurovirul
suckl
mice
hanley
et
al
moreov
larg
number
specif
mutat
e
protein
domain
tbev
jev
mvev
yfv
shown
affect
either
neuroinvas
neurovirul
mice
review
hurrelbrink
mcminn
mandl
introduct
variou
amino
acid
substitut
elong
factor
bind
site
adjac
area
termin
stemloop
sl
utr
wnv
infecti
clone
shown
mutat
decreas
bind
effici
viral
sl
vitro
neg
effect
viral
minusstrand
rna
synthesi
cellulo
vice
versa
mutat
increas
bind
effici
davi
et
al
also
show
coloc
viral
replic
complex
infect
cell
strongli
suggest
interact
cellular
protein
sl
wnv
genom
rna
facilit
viral
minusstrand
rna
synthesi
interact
sl
host
cellular
factor
report
role
identifi
use
approach
similar
describ
interact
tcell
intracellular
antigenrel
tiar
protein
tcell
intracellular
protein
wnv
minu
sl
rna
sl
rna
character
emara
et
al
use
vitro
experi
specif
bind
site
wnv
sl
rna
identifi
effect
mutat
viru
replic
within
bind
site
analyz
effici
genom
rna
synthesi
viru
product
progress
decreas
decreas
vitro
bind
effici
mutant
sl
rna
experi
neither
tiar
found
bind
sl
sl
genom
rna
fact
sever
mutant
rna
ineffici
interact
vitro
rapidli
revert
vivo
indic
could
replic
low
level
suggest
interact
viral
sl
rna
requir
initi
lowlevel
symmetr
rna
replic
instead
facilit
subsequ
asymmetr
amplif
genom
rna
minusstrand
templat
anoth
studi
domain
prm
protein
might
respons
interact
vacuolar
atpas
vatpas
analyz
use
sever
denv
delet
prm
region
critic
residu
locat
pr
portion
protein
highli
conserv
among
member
flaviviru
respons
bind
vatpas
identifi
duan
et
al
use
specif
inhibitor
vatpas
inhibit
endosom
lysosom
acidif
demonstr
interact
play
import
role
mediat
lowph
depend
entri
denv
also
establish
suitabl
ph
environ
facilit
effici
viru
secret
research
focus
identif
understand
mechan
involv
viral
evas
host
immun
respons
also
benefit
significantli
develop
improv
revers
genet
methodolog
thu
demonstr
incorpor
mutat
kunv
genom
result
mutant
viru
elicit
rapid
induct
higher
level
synthesi
ifnab
infect
human
cell
compar
unmodifi
kunv
introduc
mutat
induc
drastic
diminut
kunv
neuroinvas
neurovirul
mice
viru
also
partial
attenu
ifnabc
receptor
knockout
mice
thu
mutat
may
also
play
role
effici
activ
antivir
pathway
also
shown
mutant
kunv
defici
product
sfrna
replic
poorli
wt
mice
mous
embryon
fibroblast
mef
howev
virul
mutant
viru
larg
rescu
mice
combin
defici
major
factor
involv
type
ifn
respons
transcript
regul
act
downstream
defici
type
alphabeta
interferon
receptor
ifnar
suggest
contribut
sfrna
overcom
antivir
respons
mediat
type
ifn
schuessler
et
al
also
remain
differ
virul
wt
sfrnadefici
viru
ifn
responsedefect
mice
suggest
limit
contribut
ifnindepend
antivir
respons
restrict
virul
sfrnadefici
viru
mani
recogn
flavivirus
arbovirus
ie
transmit
vertebr
bite
infect
arthropod
howev
other
includ
insectspecif
flavivirus
isfv
nonknownvector
nkv
flavivirus
arbovirus
viral
determin
respons
host
tropism
vector
specif
remain
larg
undefin
order
explor
role
utr
host
specif
chimer
genom
gener
utr
capsid
andor
utr
encod
region
mosquitoborn
replac
separ
combin
tickborn
lgtv
none
chimer
genom
yield
detect
viru
follow
transfect
replac
variabl
region
vr
utr
lgtv
show
lower
replic
wildtyp
parent
mammalian
cell
mosquito
cell
abl
infect
mosquito
vivo
moreov
lgtv
abl
infect
tick
tumban
et
al
result
suggest
utr
exchang
tickborn
mosquitoborn
flavivirus
vr
affect
mode
transmiss
studi
whether
viral
e
protein
play
role
abil
flavivirus
infect
mosquito
cell
replic
two
chimer
flavivirus
monitor
experi
prme
region
anchcprm
region
mosquitoborn
flavivirus
replac
correspond
region
nkv
flaviviru
modoc
viru
modv
chimer
virus
replic
effici
mammalian
verob
mosquito
cell
wherea
infecti
modv
rna
fail
replic
mosquito
cell
charlier
et
al
observ
suggest
inabl
nkv
flavivirus
replic
arthropod
cell
determin
viral
e
protein
appear
occur
postentri
stage
like
due
differ
host
protein
profil
mammalian
arthropod
cell
result
obtain
saiyasombat
et
al
use
similar
approach
corrobor
observ
indic
vertebr
host
specif
modv
could
condit
genet
element
locat
outsid
prme
region
saiyasombat
et
al
report
gene
abil
monitor
rapidli
quantit
viru
replic
virtu
report
gene
activ
provid
numer
applic
analysi
differ
facet
flaviviru
biolog
vitro
vivo
inde
detect
system
recombin
viru
express
report
gene
monitor
realtim
may
shorten
amount
time
need
conduct
antivir
assay
develop
novel
therapeut
anoth
power
applic
studi
viru
tropism
vivo
report
gene
use
identifi
initi
cellular
target
infect
cell
migrat
viru
exposur
mechan
viru
penetr
central
nervou
system
infecti
molecular
clone
capabl
express
high
level
report
gene
infect
cell
also
describ
thu
gene
encod
green
fluoresc
protein
gfp
clone
utr
viral
genom
translat
control
intern
ribosom
entri
site
ire
encephalomyocard
viru
emcv
transfect
cell
infecti
dna
plasmid
result
product
infecti
wnv
capabl
mediat
highlevel
express
gfp
sever
differ
cell
type
pierson
et
al
approach
also
use
clone
renilla
luciferas
report
gene
puigbasago
et
al
zou
et
al
hand
use
differ
approach
construct
cdna
clone
encod
renilla
luciferas
report
gene
inde
fragment
encompass
first
amino
acid
capsid
protein
renilla
luciferas
gene
sequenc
footandmouth
diseas
viru
insert
junction
utr
orf
viral
genom
duplic
ntermin
amino
acid
capsid
protein
use
maintain
rna
element
requir
genom
cycliz
alvarez
et
al
alvarez
et
al
frieb
harri
sequenc
use
ensur
luciferas
protein
properli
process
similar
approach
use
schoggin
et
al
gener
infecti
express
either
gfp
firefli
luciferas
construct
use
follow
dynam
denv
infect
mice
bioluminesc
imag
identifi
ifnstimul
gene
isg
antidenv
activ
screen
denvgfp
librari
isg
schoggin
et
al
howev
worth
note
although
construct
present
great
potenti
often
remain
unstabl
continu
cell
passag
andor
exhibit
decreas
fit
compar
wildtyp
viral
protein
function
protein
two
amino
acid
substitut
contribut
sever
impair
gener
viru
infect
identifi
revers
genet
studi
util
infecti
clone
kunv
liu
et
al
use
sitedirect
mutagenesi
demonstr
mutat
locat
protein
induc
sever
inhibit
rna
replic
introduc
mutat
protein
block
viru
assembl
andor
secret
addit
sequenc
analysi
recov
virus
show
amino
acid
revert
wildtyp
sequenc
demonstr
function
import
residu
viral
replic
andor
viral
assembl
import
capsid
protein
intern
hydrophob
domain
isol
viabl
mutant
tbev
carri
extend
delet
capsid
protein
demonstr
infecti
particl
form
even
entir
central
hydrophob
domain
remov
howev
result
show
larg
delet
toler
follow
acquisit
addit
mutat
increas
hydrophob
protein
suggest
may
compens
loss
central
hydrophob
domain
kofler
et
al
result
corrobor
notion
hydrophob
interact
protein
c
essenti
assembl
infecti
particl
illustr
individu
residu
within
central
hydrophob
domain
absolut
requir
infect
infecti
clone
use
investig
import
extend
loop
motif
f
g
beta
strand
fg
loop
locat
domain
iii
diii
e
protein
delet
substitut
amino
acid
loop
mimic
motif
present
mosquitoborn
tickborn
flavivirus
shown
retent
diii
fg
loop
structur
import
wherea
specif
amino
acid
sequenc
vari
provid
loop
maintain
erb
et
al
observ
relat
viral
infect
replic
mammalian
cell
well
aed
aegypti
mosquito
midgut
cell
fg
loop
found
dispens
fg
loop
mutant
abl
bind
enter
mammalian
cell
replic
mutant
mimick
tickborn
fgloop
delay
vero
cell
secondari
mutat
appear
find
emphas
import
e
protein
diii
fg
loop
structur
denv
infect
replic
mosquito
mammalian
cell
protein
modif
glycosyl
order
investig
import
protein
glycosyl
sitedirect
mutagenesi
full
length
infecti
clone
use
creat
mutant
virus
lack
glycosyl
site
crabtre
et
al
result
show
virus
alter
either
posit
exhibit
reduc
growth
characterist
cell
reduc
secret
infect
cell
decreas
neurovirul
mous
model
ablat
glycosyl
site
result
unstabl
virus
acquir
numer
addit
mutat
taken
togeth
result
indic
glycosyl
viru
protein
may
influenc
protein
process
transport
well
pathogen
viru
use
infecti
clone
deriv
wnv
strain
glycosyl
within
e
protein
shown
enhanc
neuroinvas
mous
virul
model
beasley
et
al
introduct
prme
gene
strain
attenu
mous
neuroinvas
possess
mutat
abolish
glycosyl
motif
residu
infecti
clone
highli
neuroinvas
strain
specif
mutat
residu
abolish
glycosyl
result
attenu
viru
level
compar
furthermor
mutat
permit
glycosyl
e
protein
backbon
yield
viru
virul
equival
result
confirm
highli
virul
mous
neuroinvas
phenotyp
strain
compar
attenu
mous
neuroinvas
phenotyp
strain
primarili
mediat
via
presenc
e
protein
glycosyl
motif
nonessenti
dimeris
demonstr
singl
amino
acid
substitut
conserv
prolin
residu
protein
kunv
result
loss
dimer
format
without
inhibit
viru
replic
correct
traffick
protein
infect
cell
hall
et
al
howev
viru
yield
reduc
virul
diminish
contrari
previous
report
result
demonstr
dimeris
flaviviru
protein
essenti
requir
protein
secret
viru
replic
neurovirul
mice
wright
pryor
et
al
observ
confirm
shown
homolog
substitut
residu
mvev
protein
also
abolish
dimer
replic
effici
mutant
viru
reduc
mammalian
cell
neuroinvas
reduc
weanl
mice
clark
et
al
cycliz
sequenc
rna
secondari
structur
cycliz
sequenc
use
atom
forc
microscopi
rna
bind
assay
first
shown
known
cycliz
sequenc
present
mosquitoborn
flavivirus
mbfv
essenti
format
rnarna
complex
format
alvarez
et
al
howev
addit
complementari
sequenc
present
end
immedi
upstream
initi
aug
region
uar
end
within
sl
uar
viral
rna
also
shown
requir
order
investig
function
role
uar
sequenc
mutat
either
separ
destroy
base
pair
simultan
restor
complementar
denv
infecti
clone
nonviabl
virus
recov
transfect
denv
mutant
carri
specif
substitut
within
uar
mutant
contain
compensatori
mutat
restor
complementar
abl
replic
demonstr
base
pair
uar
provid
essenti
element
viral
viabil
cycliz
rna
requir
conform
viral
replic
alvarez
et
al
cisact
element
use
structur
predict
biochem
analysi
liu
et
al
identifi
novel
conserv
cisact
element
downstream
cycliz
sequenc
pseudoknot
dcspk
threestem
pseudoknot
structur
locat
capsidcod
region
mosquitoborn
flavivirus
liu
et
al
mutagenesi
infecti
clone
reveal
disrupt
dcspk
structur
hinder
abil
rna
bind
rna
wherea
restor
dcspk
structur
facilit
recoveri
complex
demonstr
role
viral
replic
mutagenesi
also
show
function
dcspk
depend
posit
rel
cycliz
sequenc
secondari
structur
specif
primari
sequenc
base
result
author
propos
cisact
element
dcspk
enhanc
viral
replic
regul
genom
cycliz
dcspk
might
interact
cisact
element
form
function
viral
rna
cycliz
domain
thu
play
critic
role
flaviviru
life
cycl
replic
enhanc
element
uniqu
replic
enhanc
element
ree
identifi
within
capsid
gene
tbev
tuplin
et
al
use
thermodynam
phylogenet
analys
predict
ree
fold
long
stabl
stemloop
structur
design
expos
conserv
hexanucleotid
among
tickborn
flavivirus
tbfv
investig
role
tbev
infecti
clone
use
introduc
nucleotid
substitut
alter
either
linear
sequenc
unpair
apic
loop
destabil
basepair
stem
greatest
phenotyp
chang
observ
mutant
destabil
stem
point
mutat
conserv
hexanucleotid
motif
termin
loop
caus
moder
viru
attenu
howev
fact
mutant
eventu
reach
titer
wildtyp
viru
late
postinfect
demonstr
ree
essenti
growth
tissu
cultur
act
upregul
viru
replic
cartographi
utr
studi
flavivir
utr
sequenc
attract
consider
interest
led
depth
silico
analys
gritsun
gould
gritsun
et
al
gritsun
et
al
likewis
infecti
clone
use
map
defin
character
variou
compon
part
utr
seri
progress
delet
introduc
utr
infecti
clone
viabil
result
mutant
analyz
delet
conserv
sequenc
cs
distal
region
highli
conserv
wide
diverg
mbfv
group
complet
abolish
infect
indic
sequenc
essenti
viru
replic
contrast
delet
either
also
conserv
mbfv
lethal
likewis
progress
upstream
delet
toward
stop
codon
yield
viabl
mutant
virus
although
exhibit
spectrum
growth
reduct
cell
cultur
thu
propos
boundari
viabl
lethal
delet
lie
immedi
upstream
delet
mutant
retain
distal
region
termin
long
stabl
hairpin
lsh
produc
viabl
viru
albeit
low
infect
mosquito
cell
infect
vertebr
cell
presenc
also
essenti
gener
impact
delet
utr
downstream
profound
primat
cell
mosquito
cell
suggest
host
factor
may
play
import
role
effici
viral
replic
similar
result
produc
use
infecti
clone
yfv
conserv
sequenc
cs
well
stem
loop
structur
found
essenti
viru
replic
cell
cultur
wherea
mutant
delet
region
contain
yfvspecif
repeat
sequenc
stop
codon
still
yield
viabl
virus
although
delay
growth
properti
smaller
plaqu
size
suggest
region
essenti
viru
viabil
may
function
relat
viru
replic
effici
bredenbeek
et
al
delet
also
introduc
utr
tbev
mandl
et
al
kunv
khromykh
westaway
silico
analysi
consequ
introduct
delet
denv
tbev
kunv
conduct
evalu
impact
secondari
structur
proutski
et
al
develop
revers
genet
method
made
possibl
develop
new
approach
product
live
attenu
vaccin
candid
creation
chimer
virus
discoveri
character
potenti
antivir
therapeut
molecul
understand
basi
appear
drug
resist
chimer
approach
vaccin
design
base
observ
structur
gene
one
flaviviru
exchang
equival
gene
relat
flavivirus
without
significantli
affect
replic
capac
deriv
recombin
chimer
viru
exampl
chimer
viru
could
contain
structur
gene
one
flaviviru
eg
prm
e
protein
remain
part
genom
includ
termin
untransl
region
anoth
flaviviru
provid
background
support
gene
encod
nonstructur
protein
provid
replic
protein
process
function
rational
behind
strategi
confer
longlast
protect
immun
pathogen
use
known
attenu
viru
provid
backbon
function
immun
antigen
e
prm
protein
contain
critic
antigen
determin
induc
protect
neutral
antibodi
feasibl
approach
first
demonstr
bray
lai
construct
first
intertyp
denv
chimera
entir
structur
region
cprme
gene
envelop
protein
gene
prme
wildtyp
strain
well
nonstructur
protein
success
replac
correspond
gene
bray
et
al
chen
et
al
chimera
grew
cell
cultur
display
expect
antigen
specif
elicit
protect
level
expect
neutral
antibodi
monkey
studi
repres
foundat
construct
varieti
chimer
flavivirus
develop
potenti
live
human
vaccin
due
impress
safeti
record
high
efficaci
human
vaccin
attenu
yfv
strain
use
backbon
construct
chimer
vaccin
virus
see
fig
first
develop
chamber
et
al
monath
et
al
gener
yfvjev
chimera
chamber
et
al
monath
et
al
yfvbase
chimer
candid
vaccin
subsequ
construct
denv
caufour
et
al
guirakhoo
et
al
guirakhoo
et
al
guirakhoo
et
al
van
der
et
al
jev
monath
et
al
monath
et
al
wnv
arroyo
et
al
monath
et
al
monath
et
al
saint
loui
enceph
viru
pugachev
et
al
extens
test
clinic
trial
result
demonstr
immunogen
good
safeti
profil
guy
et
al
guy
et
al
structur
gene
either
deriv
wild
type
wt
virus
eg
denv
veterinari
wnv
vaccin
candid
empir
deriv
attenu
vaccin
eg
jev
strain
introduct
specif
attenu
mutat
wildtyp
e
gene
site
direct
mutagenesi
eg
strain
develop
human
wnv
vaccin
jev
strain
also
use
backbon
produc
wnvjev
tbevjev
attenu
chimera
li
et
al
b
wang
et
al
chimer
wnv
vaccin
candid
also
report
maximova
et
al
pletnev
et
al
issu
possibl
occurr
recombin
chimer
viru
wt
flaviviru
could
lead
product
recombin
viru
unanticip
properti
rais
remain
unansw
seligman
gould
infecti
clone
use
character
antivir
drug
resist
mechan
exampl
resist
mutant
obtain
cellulo
passag
viru
increas
concentr
antivir
drug
character
use
revers
genet
method
infecti
clone
introduc
candid
mutat
genom
infecti
clone
resist
phenotyp
mutat
viru
determin
approach
use
character
antivir
properti
brequinar
bqr
use
denv
qing
et
al
appropri
mutant
select
cell
cultur
follow
sequenc
appropri
mutagenesi
infecti
clone
demonstr
mutat
either
envelop
gene
confer
bqr
resist
mechanist
envelop
mutat
render
mutant
viru
less
suscept
bqr
inhibit
assemblyreleas
phase
wherea
mutat
confer
resist
enhanc
viral
rna
synthesi
anoth
studi
yang
et
al
use
stabl
reporterdenv
replicon
cell
line
identifi
small
molecul
inhibitor
specif
inhibit
four
serotyp
denv
sequenc
analys
isol
resist
mutant
identifi
consensu
amino
acid
substitut
present
within
proteas
domain
introduct
mutat
infecti
clone
result
apparit
resist
phenotyp
locat
mutat
within
interfac
proteas
helicas
domain
denv
protein
indic
may
affect
denv
replic
bind
proteas
interfac
schemat
represent
gener
approach
design
yfv
chimer
vaccin
candid
sequenc
encod
prm
e
protein
vaccin
target
viru
eg
jev
wnv
denv
slev
engin
cdna
genom
yfv
vaccin
strain
replac
authent
prm
e
sequenc
chimer
viral
rna
obtain
vitro
transcript
transfect
permiss
cell
result
product
infecti
chimer
viru
particl
cover
vaccin
target
viru
envelop
protein
avail
cdna
clonespcramplicon
facilit
studi
genet
express
replic
pathogenesi
rna
virus
use
mutagenesi
delet
insert
complement
experi
also
enhanc
understand
molecular
mechan
natur
induc
rna
recombin
well
viru
interact
host
cell
organ
product
infecti
clone
essenti
step
develop
revers
genet
system
begin
enabl
acquisit
huge
amount
knowledg
virus
democratis
technolog
de
novo
synthesi
huge
develop
made
recent
decad
made
possibl
gener
new
investig
approach
avoid
need
use
critic
step
infecti
clone
construct
clone
propag
cdna
bacteria
vitro
rna
transcript
thu
provid
easier
faster
reliabl
method
unravel
scientif
mysteri
discuss
review
methodolog
undoubtedli
continu
improv
becom
even
access
potenti
ensur
increasingli
excit
futur
scientif
investig
